Effects of buffered and plain acetylsalicylic acid formulations with and without ascorbic acid on gastric mucosa in healthy subjects

Alimentary Pharmacology and Therapeutics

Volumn 19, Issue 3, 2004, Pages 367-374

  Dammann, H G ^a   Saleki, M ^a   Torz, M ^a   Schulz, H U ^b   Krupp, S ^b   Schurer M ^b   Timm, J ^c   Gessner, U ^d  

^a Klinische Forschung Hamburg   (Germany)

^b LAFAA Lab Contract Res Clin P   (Germany)

^c UNIVERSITY OF BREMEN   (Germany)

^d BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ASCORBIC ACID; BUFFER; CAFFEINE; PARACETAMOL;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; DRUG TOLERABILITY; DUODENUM BLEEDING; ENDOSCOPY; ESOPHAGUS HEMORRHAGE; FEMALE; GASTROINTESTINAL DISEASE; HEMOGLOBIN DETERMINATION; HUMAN; MALE; NORMAL HUMAN; PETECHIA; PRIORITY JOURNAL; STOMACH HEMORRHAGE; STOMACH MUCOSA; STOMACH SUCTION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; ASCORBIC ACID; ASPIRIN; CROSS-OVER STUDIES; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; PROSPECTIVE STUDIES; RISK FACTORS; STOMACH DISEASES;

EID: 1342331526     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.01742.x     Document Type: Article

References (25)

1. Food and Drug Administration Nonprescription Drugs Advisory Committee. Briefing Information. Section III: NSAID/Aspirin Reviews: Aspirin - GI Bleed, NSAID - GI Bleed September 19, 2002. In: http://www.fda.gov/ohrms/dockets/ac/02/ briefing/3882b1.htm; accessed January 28, 2003.
2. Edwards JE, Oldman A, Smith L, et al. Single dose oral aspirin for acute pain. Cochrane Database Syst Rev 2000; 2: CD002067.
3. Henry D, Lim LL, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative metaanalysis. Br Med J 1996; 312: 1563-6.
4. Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996; 348: 1413-6.
5. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994; 330(18): 1287-94.
6. Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995; 310: 827-30.
7. Roderick PJ, Wilkes HC, Meade TW. The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol 1993; 35(3): 219-26.
8. Hoftiezer JW, O'Laughlin JC, Ivey KJ. Effects of 24 hours of aspirin, Bufferin, paracetamol and placebo on normal human gastroduodenal mucosa. Gut 1982; 23(8): 692-7.
9. Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med 1986; 104(3): 390-8.
10. Hawthorne AB, Mahida YR, Cole AT, Hawkey CJ. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. Br J Clin Pharmacol 1991; 32(1): 77-83.
11. Stern AI, Ward F. Buffered aspirin is less damaging to the human gastric mucosa than regular aspirin. Gastroenterology 1985; 88(5): 1600.
12. Goeke B, Arnold R. Buffering protects against aspirin-induced gastric-mucosal injury. Med Klinik 1989; 84(10): 474-8.
13. Hawkey CJ. Review article: aspirin and gastrointestinal bleeding. Aliment Pharmacol Ther 1994; 8(2): 141-6.
14. McAlindon ME, Muller AF, Filipowicz B, Hawkey CJ. Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers. Gut 1996; 38(4): 518-24.
15. 2 blockers, prostaglandins and omeprazole. Z Rheumatol 1986; 45(4): 182.
16. Tolman KG, Detweiler MK, Harrison CA, et al. Effect of rioprostil on aspirin-induced gastrointestinal mucosal changes in normal volunteers. J Clin Pharmacol 1988; 28(1): 76-80.
17. Lanza FL, Kochman RL, Geis GS, Rack EM, Deysach LG. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits. Am J Gastroenterol 1991; 86(12): 1743-8.
18. Stern AI, Hogan DL, Kahn LH, Isenberg JI. Acetaminophen protects the human stomach from the damaging effects of aspirin and ethanol. Gastroenterology 1983; 84(5): 1324.
19. Graham DY, Smith JL. Effects of aspirin and an aspirin-acetaminophen combination on the gastric mucosa in normal subjects. A double-blind endoscopic study. Gastroenterology 1985; 88(6): 1922-5.
20. Lanza FL. A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects. Dig Dis Sci 1986; 31(2 Suppl.): 131S-136S.
21. Hawkey CJ, Simpson G, Somerville KW. Reduction by enprostil of aspirin-induced blood loss from human gastric mucosa. Am J Med 1986; 81(2A): 50-3.
22. Hunt JN. A procedure for measuring gastric bleeding caused by drugs. Dig Dis Sci 1979; 24(7): 525-8.
23. Pohle T, Brzozowski T, Becker JC, et al. Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C. Aliment Pharmacol Ther 2001; 15(5): 677-87.
24. Motola G, Russo F, Mazzeo F, et al. Over-the-counter oral nonsteroidal anti-inflammatory drugs: a pharmacoepidemiologic study in southern Italy. Adv Ther 2001; 18(5): 216-22.
25. Steiner TJ, Lange R, Voelker M. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 2003; 23(1): 59-66.